Shao Kang Wang
Chief Executive Officer at Infervision Medical Technology Co., Ltd.
Profile
Shao Kang Wang is currently the Executive Director & General Manager at Infervision Medical Technology Co., Ltd.
and a Member-Supervisory Board at Shanghai Infervision Biotechnology Co. Ltd.
He graduated from The University of Chicago in 2012 with a graduate degree and from Beijing Institute of Technology in 2010 with an undergraduate degree.
Shao Kang Wang active positions
Companies | Position | Start |
---|---|---|
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | Chief Executive Officer | 04/01/2016 |
Shanghai Infervision Biotechnology Co. Ltd. | Director/Board Member | 31/12/2019 |
Training of Shao Kang Wang
The University of Chicago | Graduate Degree |
Beijing Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | Technology Services |
Shanghai Infervision Biotechnology Co. Ltd. |
- Stock Market
- Insiders
- Shao Kang Wang